Cardinal Health, Inc. (CAH)
Market Cap | 29.12B |
Revenue (ttm) | 224.45B |
Net Income (ttm) | 1.28B |
Shares Out | 242.01M |
EPS (ttm) | 5.21 |
PE Ratio | 23.11 |
Forward PE | 15.11 |
Dividend | $2.02 (1.68%) |
Ex-Dividend Date | Oct 1, 2024 |
Volume | 1,268,357 |
Open | 118.36 |
Previous Close | 118.33 |
Day's Range | 118.03 - 120.41 |
52-Week Range | 93.17 - 126.14 |
Beta | 0.62 |
Analysts | Buy |
Price Target | 123.00 (+2.21%) |
Earnings Date | Nov 1, 2024 |
About CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare... [Read more]
Financial Performance
In 2024, Cardinal Health's revenue was $226.83 billion, an increase of 10.66% compared to the previous year's $204.98 billion. Earnings were $852.00 million, an increase of 158.18%.
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for CAH stock is "Buy." The 12-month stock price forecast is $123.0, which is an increase of 2.21% from the latest price.
News
Cardinal Health launches Kendall SCD SmartFlow™ Compression System
Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio , Nov. 20, 2024 /PRNewswire/ -- Cardinal Health (NYSE...
Cardinal Health, Inc. (CAH) UBS Global Healthcare Conference (Transcript)
Cardinal Health, Inc. (NYSE:CAH) UBS Global Healthcare Conference November 12, 2024 11:00 AM ET Company Participants Matt Sims - Vice President, Investor Relations Aaron Alt - Chief Financial Officer...
Court Square Capital Partners Announces Sale of Advanced Diabetes Supply Group
NEW YORK--(BUSINESS WIRE)--Court Square Capital Partners (“Court Square”), a leading middle-market private equity company, announced today it has entered a definitive agreement in the sale of Advanced...
GI Alliance to Partner with Cardinal Health Creating a Scaled Multi-Specialty Managed-Services Platform to Benefit Physicians and Patients
Adds the country's leading gastroenterology (GI) management services organization (MSO) to Cardinal Health's Specialty portfolio supporting over 900 physicians in 345 practices in 20 states Adds the c...
Cardinal Health buys GI Alliance and Advanced Diabetes Supply Group for about $3.9 bln
Cardinal Health said on Monday it acquired majority stakes in GI Alliance and Advanced Diabetes Supply Group (ADSG) for about $2.8 billion and $1.1 billion each in an all cash deal.
Cardinal Health announces two strategic additions to its portfolio
Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition of ...
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio , Nov. 5, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surp...
Cardinal Health Q1 Earnings: Margins Signal More Upside
Cardinal Health's Q1 2025 earnings reaffirm my buy rating due to a strengthening pharmacy business and industry tailwinds. Despite initial market overreaction to 2025 guidance, Cardinal Health's manag...
Cardinal Health Stock Hits All-Time High as Existing Customers Power Results
Cardinal Health (CAH) shares hit a new all-time intraday high Friday as the healthcare products provider posted better-than-expected results and raised its outlook even as it took a financial hit from...
Cardinal Health, Inc. (CAH) Q1 2025 Earnings Call Transcript
Cardinal Health, Inc. (NYSE:CAH) Q1 2025 Earnings Conference Call November 1, 2024 8:30 AM ET Company Participants Matt Sims - Vice President, Investor Relations Jason Hollar - Chief Executive Office...
Cardinal Health lifts annual profit outlook on strength in specialty medicines unit
Cardinal Health raised its 2025 adjusted profit forecast on Friday as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit, sending the shares of the ...
Cardinal Health Reports First Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook
Revenue decreased 4% to $52.3 billion; revenue increased 15% excluding the impact of the previously communicated large customer contract expiration GAAP 1 operating earnings were $568 million; GAAP di...
Cardinal Health celebrates medical product distribution center grand opening in Massachusetts
New facility in Boylston increases U.S. warehouse capacity and expands specialized handling capabilities DUBLIN, Ohio , Oct. 29, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the gr...
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2025 on November 1
DUBLIN, Ohio , Sept. 24, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2025 on November 1, prior to the opening of trading on th...
Cardinal Health to acquire Integrated Oncology Network for $1.12 billion
Cardinal Health on Friday agreed to acquire Integrated Oncology Network, an independent community oncology network, for $1.12 billion in cash.
Cardinal Health to acquire Integrated Oncology Network, a physician-led independent community oncology network
Transaction demonstrates Cardinal Health's continued strategic investment in specialty and oncology, underscores commitment to independent community healthcare providers Accelerates the development o...
Bioactive Dressings - Comprehensive Global and Regional Market Forecast to 2029 - Featuring Strategical Analysis of 3M, Smith+Nephew, Cardinal Health, Braun, Molnlycke Health Care, Convatec & More
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Bioactive Dressings Market by Product (Collagen, Alginate, Chitosan, Skin Substitute), Property (Antimicrobial, Non-Antimicrobial), Application (Chronic...
Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®
MELBOURNE, Australia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal He...
Cardinal Health, Inc. (CAH) Baird's 2024 Global Healthcare Conference (Transcript)
Cardinal Health, Inc. (NYSE:CAH) Baird's 2024 Global Healthcare Conference September 10, 2024 9:05 AM ET Company Participants Matt Sims - VP, IR Jason Hollar - CEO Aaron Alt - CFO Conference Call Par...
Children's Hospital Association and Cardinal Health commemorate World Suicide Prevention Day with continued focus on youth mental health
WASHINGTON and DUBLIN, Ohio , Sept. 10, 2024 /PRNewswire/ -- In observance of today's World Suicide Prevention Day, Children's Hospital Association (CHA), Cardinal Health (NYSE: CAH), and Zero Suicide...
Cardinal Health (CAH) Morgan Stanley 22nd Annual Global Healthcare Conference Transcript
Cardinal Health, Inc. (NYSE:CAH) Morgan Stanley 22nd Annual Global Healthcare Conference September 5, 2024 8:30 AM ET Company Participants Matt Sims - VP, IR Aaron Alt - CFO Conference Call Participa...
Cardinal Health celebrates Greenville, South Carolina, distribution center opening
'Warehouse of the Future' to expand nationwide distribution network in support of home healthcare growth DUBLIN, Ohio , Aug. 28, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) officially announced t...
Cardinal Health Q4 Earnings: FY25 Is A Short-Term Blip
Cardinal Health stock remains a buy due to strong pharmaceutical business growth and increased shareholder returns, despite short-term OptumRx and inflation challenges. Q4 and FY24 earnings exceeded e...
Cardinal Health Soars as America's Leading Acute Care Supplier
Cardinal Health Inc. CAH is a global pharmaceutical and medical products distributor serving over 100,000 hospitals. It's also the largest distributor of medical supplies and surgical products in the ...
Bert's July Dividend Income Summary (2024)
In July 2024, we received $1,683.75 in dividend income. We have been buying at least 4 shares of SCHD every single week. I accepted a long time ago that Leggett & Platt's dividend cut was terrible.